Remedium Capital Partners, Llc

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value
$281.2M
Q ending 2026-03-31
Prior quarter
$170K
Q ending 2025-12-31
Change
+165077.4% QoQ
Positions
6
reported holdings

Largest positions

All 6 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
HoldingTickerTypeValueShares
Oruka Therapeutics IncORKAShares$76.8M1.6M
Spyre Therapeutics IncSYREShares$73.5M1.5M
Damora Therapeutics IncDMRAShares$53.0M2.0M
Apogee Therapeutics IncAPGEShares$49.1M584K
Jade Biosciences IncJBIOShares$22.2M1.6M
Crescent Biopharma IncShares$6.6M361K

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.